Hemoglobin Oxygen Therapeutics is a Pennsylvania-based biopharmaceutical company developing oxygen-carrying solutions. Their filings show they engage a lobbying firm, MerKava Strategies, likely to represent the company’s interests in federal policy affecting biopharma or medical products. Public filings list four reports with no spending disclosed.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
This client has not yet disclosed issue activity in the available filings.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
No lobbyists are disclosed for this client yet.
The latest disclosures for this client.
MERKAVA STRATEGIES CORPORATION
Q4YMERKAVA STRATEGIES CORPORATION
Q3YMERKAVA STRATEGIES CORPORATION
The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
MERKAVA STRATEGIES CORPORATION
Q1Y